Environmental arsenic as a disruptor of insulin signaling.
Previous laboratory studies have shown that exposures to inorganic As (iAs) disrupt insulin production or glucose metabolism in cellular and animal models. Epidemiological evidence has also linked chronic human exposures to iAs to an increased risk of diabetes mellitus, a metabolic disease characterized by impaired glucose tolerance and insulin resistance. We have recently shown that arsenite and its methylated metabolites inhibit insulin-stimulated glucose uptake in cultured adipocytes by disrupting insulin-activated signal transduction pathway and preventing insulin-dependent translocation of GLUT4 transporters to the plasma membrane. Here, we present results of follow-up studies using male C57BL/6 mice chronically exposed to arsenite (1 to 50 ppm As) or to its metabolite methylarsonite (0.1 to 5 ppm As) in drinking water for 8 weeks. Results of these studies show that only the exposure to arsenite at the highest level of 50 ppm As produces symptoms attributable to impaired glucose tolerance. Notably, tissue concentrations of iAs and its methylated metabolites in pancreas and in major glucose metabolizing tissues in mice in this exposure group were comparable to the concentrations of total As reported in livers of Bangladeshi residents exposed to much lower concentrations of iAs in drinking water. These results suggest that because mice clear iAs and its metabolites more rapidly than humans, much higher exposure levels may be needed in mouse studies to produce the diabetogenic effects of iAs commonly found in human populations exposed to iAs from environmental sources.
Paul
David S
DS
Department of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, USA.
Devesa
Vicenta
V
Hernandez-Zavala
Araceli
A
Adair
Blakely M
BM
Walton
Felecia S
FS
Drobnâ
Zuzana
Z
Thomas
David J
DJ
Styblo
Miroslav
M
Int J Environ Health Res. 2002 Sep;12(3):235-53
12396524
IARC Monogr Eval Carcinog Risks Hum. 2004;84:1-477
15645577
Environ Res. 2007 Jul;104(3):383-9
17475235
Environ Health Perspect. 2007 May;115(5):734-42
17520061
Environ Health Perspect. 2006 May;114(5):641-8
16675414
Toxicol Appl Pharmacol. 2007 Aug 1;222(3):305-14
17336358
Toxicol Appl Pharmacol. 2005 Oct 15;208(2):186-97
16183392
Toxicol Appl Pharmacol. 2005 Aug 7;206(2):169-75
15967205